相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。p53 mutation, deprivation and poor prognosis in primary breast cancer
L. Baker et al.
BRITISH JOURNAL OF CANCER (2010)
PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
Elena Lopez-Knowles et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Sandra E. Ghayad et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2010)
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
Aslaug Aa Muggerud et al.
BREAST CANCER RESEARCH (2010)
High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer
Henne Holstege et al.
CANCER RESEARCH (2009)
High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors
Elodie Manie et al.
CANCER RESEARCH (2009)
PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
Kevin Kalinsky et al.
CLINICAL CANCER RESEARCH (2009)
PIK3CA in Breast Carcinoma A Mutational Analysis of Sporadic and Hereditary Cases
Angela Michelucci et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2009)
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
Judith Hugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution
Wenjing Zhou et al.
MOLECULAR ONCOLOGY (2009)
Restoring p53 Function in Cancer: Novel Therapeutic Approaches for Applying the Brakes to Tumorigenesis
Alessandra Cintio et al.
Recent Patents on Anti-Cancer Drug Discovery (2009)
Awakening guardian angels: drugging the p53 pathway
Christopher J. Brown et al.
NATURE REVIEWS CANCER (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer
Birgitte Vrou Offersen et al.
ACTA ONCOLOGICA (2008)
Integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
Katherine Stemke-Hale et al.
CANCER RESEARCH (2008)
PTEN: a new guardian of the genome
Y. Yin et al.
ONCOGENE (2008)
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles
F. Bertucci et al.
ONCOGENE (2008)
Hereditary diffuse gastric cancer: association with lobular breast cancer
Kasmintan A. Schrader et al.
FAMILIAL CANCER (2008)
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
Berengere Marty et al.
BREAST CANCER RESEARCH (2008)
The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations
Chuan-Hsiang Huang et al.
SCIENCE (2007)
The genomic landscapes of human breast and colorectal cancers
Laura D. Wood et al.
SCIENCE (2007)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit
Nabil Miled et al.
SCIENCE (2007)
PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer
Gizeh Perez-Tenorio et al.
CLINICAL CANCER RESEARCH (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Patterns of somatic mutation in human cancer genomes
Christopher Greenman et al.
NATURE (2007)
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Anita Langerod et al.
BREAST CANCER RESEARCH (2007)
The consensus coding sequences of human breast and colorectal cancers
Tobias Sjoeblom et al.
SCIENCE (2006)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
PIK3CA mutations in breast cancer are associated with poor outcome
SY Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
M Olivier et al.
CLINICAL CANCER RESEARCH (2006)
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
LH Saal et al.
CANCER RESEARCH (2005)
Low frequency of E-cadherin alterations in familial breast cancer
S Salahshor et al.
BREAST CANCER RESEARCH (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
